Calliditas Therapeutics AB Sponsored ADR EBITDA Margin 2020-2024 | CALT
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Calliditas Therapeutics AB Sponsored ADR (CALT) over the last 10 years. The current EBITDA margin for Calliditas Therapeutics AB Sponsored ADR as of June 30, 2024 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-06-30 | $0.15B | $-0.03B | -22.67% |
| 2024-03-31 | $0.12B | $-0.04B | -30.65% |
| 2023-12-31 | $0.11B | $-0.04B | -30.70% |
| 2023-09-30 | $0.11B | $-0.03B | -29.82% |
| 2023-06-30 | $0.11B | $-0.02B | -19.64% |
| 2023-03-31 | $0.09B | $-0.04B | -38.71% |
| 2022-12-31 | $0.08B | $-0.04B | -51.25% |
| 2022-09-30 | $0.04B | $-0.07B | -173.17% |
| 2022-06-30 | $0.04B | $-0.07B | -171.79% |
| 2021-09-30 | $0.02B | $-0.05B | -221.74% |
| 2020-12-31 | $0.00B | $-0.04B | inf% |
| 2020-03-31 | $0.02B | $-0.01B | -25.00% |
